ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Oral Abstract Session

Novel Approaches to Mineral and Bone Metabolism

October 22, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

  • Bone and Mineral Metabolism

Moderator

  • Wei Chen, MD, MS, FASN

Presentations

  • Heparin Aggravates Cardiac Injury in Animal Models with High FGF-23
    05:00 PM - 07:00 PM
    Dominik Kentrup, PhD 
  • Hypoxia-Inducible Factor 1 Alpha Regulates FGF-23 Production and Bone Metabolism in CKD
    05:00 PM - 07:00 PM
    Guillaume Courbon, MS, PhD 
  • Deletion of the Sodium/Hydrogen Exchanger Isoform 6 in Mice Is Associated with an Age-Dependent Loss of Bone Volume
    05:00 PM - 07:00 PM
    Daniela Hanke, PhD 
  • Circadian PTH Secretion Is Entrained by Feeding, While the Internal Circadian Parathyroid Clock Is Independent but Affected by CKD
    05:00 PM - 07:00 PM
    Søren Egstrand, PhD 
  • A Single-Cell Transcriptome Atlas of Adult Parathyroids in Secondary Parathyroidism
    05:00 PM - 07:00 PM
    Shensen Li, MD, PhD
  • Calcium Isotopes: A Novel Biomarker of Bone Mineralization in CKD
    05:00 PM - 07:00 PM
    Rukshana Shroff, MD, PhD 
  • Secondary Hyperparathyroidism Is Associated with Weight Loss and Longer-Term Mortality Among Patients Undergoing Hemodialysis: Results from the Dialysis Outcomes and Practice Patterns Study
    05:00 PM - 07:00 PM
    Hirotaka Komaba, MD, PhD 
  • SNF472 Consistently Slows Progression of Coronary Artery Calcification Across Subgroups of Patients on Hemodialysis
    05:00 PM - 07:00 PM
    Glenn Matthew Chertow, MD, MPH, FASN
  • Pharmacodynamic (PD) Profiling of Reloxaliase in Patients with Severe Hyperoxaluria
    05:00 PM - 07:00 PM
    Felix Knauf, MD 
  • Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Phase 3 Study
    05:00 PM - 07:00 PM
    Tadao Akizawa, MD